Ellen Chiniara
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ellen Chiniara
Kymera Therapeutics, Inc. reported in an 8-K filed September 3, 2025 that Ellen Chiniara retired as Chief Legal Officer, effective September 3, 2025. The proxy statement of Kymera Therapeutics, Inc. reports total compensation of $5,140,813 for Ellen Chiniara in fiscal 2024, including a base salary of $461,000. Disclosed compensation is on record for 2 fiscal years.
“On August 27, 2025, Ellen Chiniara, J.D., Chief Legal Officer of Kymera Therapeutics, Inc. (the "Company"), informed the Company of her intent to retire from the role of Chief Legal Officer, effective September 3, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Kymera Therapeutics, Inc. (KYMR)
Proxy statement
Start not stated–2025-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Kymera Therapeutics, Inc. (KYMR) | Chief Legal Officer | $461,000 | $5,140,813 |
| 2023 | Kymera Therapeutics, Inc. (KYMR) | Chief Legal Officer | $433,327 | $4,962,993 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.